How Parents Hear about HPV Vaccine: Implications for Uptake by Cates, Joan R. et al.
How Parents Hear about HPV Vaccine: Implications for Uptake
Joan R. Cates, PhD, MPH1, Autumn Shafer, MA1, Francesca Dillman Carpentier, PhD1,
Paul L. Reiter, PhD2,3, Noel T. Brewer, PhD2,3, Annie-Laurie McRee, MPH2, and Jennifer S.
Smith, PhD, MPH2,3
1 School of Journalism and Mass Communication, University of North Carolina at Chapel Hill
2 UNC Gillings School of Global Public Health
3 Lineberger Comprehensive Cancer Center
Introduction
Parental awareness of the benefits of human papillomavirus (HPV) vaccine may be
especially important in maximizing uptake among adolescent females.1 Although industry-
sponsored television advertisements have been the most common source of information
about HPV vaccine reported by parents in the United States,1–3 recommendations from
children’s healthcare providers are especially influential in parental decisions about HPV
vaccination for their daughters.4–6 Other information sources commonly reported by parents
include family and friends,1, 3 Internet,1, 3 news stories1 and brochures.1, 3 Reported HPV
vaccine information sources can differ by socioeconomic group, including gender, race, age,
education and income.1 We hypothesize these differences could lead to disparities in vaccine
uptake.1
While parents may ultimately learn about the vaccine from their daughters’ providers, one
early source of information may be their daughters’ schools. At least 7 states (Indiana,
Louisiana, Michigan, New Jersey, North Carolina, Texas, and Washington, as of October,
2009) have passed legislation requiring information about HPV vaccine be distributed to
parents of adolescents through their schools.7 Whether school-based outreach to parents has
been effective in raising awareness or encouraging vaccine uptake, to our knowledge, is
largely unknown.
We examined characteristics of parents, their adolescent daughters, and households as
potential correlates of HPV vaccine awareness and information sources, and associations of
information sources with HPV vaccine initiation.
Methods
Participants were a population-based sample of 696 parents of 10–17 year old females in
North Carolina. They completed the 2008 Child Health Assessment and Monitoring
Program Survey (CHAMP) of caregivers for children under 18 years old, a follow-up survey
to the Behavioral Risk Factor Surveillance System (BRFSS) survey of adults.8
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The survey assessed parents’ HPV vaccine awareness with the question, “Have you ever
heard of the HPV vaccine?” For parents who had heard of HPV vaccine, questions assessed
whether they had heard about it from any of four possible sources: daughter’s school,
daughter’s healthcare provider, drug company advertisement, and news stories or Web sites
other than drug company advertisements. The survey assessed HPV vaccine initiation with
the question, “Has (daughter’s name) had any shots of the HPV vaccine?”
We used bivariate logistic regression models to identify correlates of HPV vaccine
awareness and information sources and entered statistically significant (p<0.05) predictors
into multivariate logistic regression models. We evaluated the four sources of information
about HPV vaccine as bivariate predictors of HPV vaccine initiation. Multivariate models
for HPV vaccine uptake controlled for variables we previously identified as multivariate
correlates of initiation.9 Analyses were weighted to reflect population characteristics of
North Carolina8 and estimated odds ratios (ORs) and associated 95% confidence intervals
(CIs).
Results
Most parents (91%) reported having heard of HPV vaccine. In multivariate analyses, parents
were less likely to be aware of HPV vaccine if they were male, or had daughters who were
non-Hispanic African American or other races/ethnicities than non-Hispanic white (Table
1). Vaccine awareness was higher among parents from households with incomes of $50,000
or higher versus under $50,000, or who reported having daughters already vaccinated
against meningitis.
Of parents who had heard of HPV vaccine, 64% had heard from drug company
advertisements, 50% from their daughters’ healthcare providers, 50% from news stories or
Web sites, and 9% from their daughters’ schools. In multivariate analyses, parents were
more likely to have heard about HPV vaccine from their daughters’ healthcare providers if
they had daughters 16–17 years old (OR=2.09, 95% CI:1.23–3.54, versus daughters aged
10–12), their daughters had received preventive check-ups in the last 12 months (OR=3.50,
95% CI: 1.97–6.24), or their daughters had received meningococcal vaccine (OR=1.64, 95%
CI:1.07–2.52). Daughters’ schools were more likely to be information sources for parents of
daughters who attended public schools (OR=4.88, 95% CI: 1.04–22.93). We found no
correlates of having heard about the vaccine through drug company advertisements or
through news stories and Web sites.
Similar to 2008 National Immunization Survey-Teen estimates for North Carolina (34%),10
31% of parents reported they had initiated HPV vaccination for their daughters. Of parents
who had heard about the vaccine from their daughters’ healthcare providers, 46% had
daughters who had started HPV vaccination (Table 2). In contrast, only 16% of parents who
had not heard about HPV vaccine from their daughters’ healthcare providers had started
vaccination for their daughters. The other three information sources were not associated with
HPV vaccine initiation.
Discussion
How parents of adolescent girls heard about HPV vaccine varied substantially in this
population-based survey. While awareness was nearly universal among parents of white and
higher income daughters, many parents of non-white or lower income daughters had not
heard of HPV vaccine. Differential consumption of news about HPV vaccine is one
potential explanation for differences in vaccine awareness.1 Most parents heard through
drug company advertising, healthcare providers, and news stories, consistent with Hughes
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(2009) and other studies.1–3 However, information sources may differently affect parents’
awareness of HPV vaccine and, ultimately, their decisions to vaccinate their daughters.
Researchers should identify media channels and vaccine messages that meet different needs
of various audiences.
This study has important strengths, including a large, population-based sample of parents
and examination of the association of sources of information with awareness and initiation
of HPV vaccine. Study limitations include the self-reported vaccine initiation measure and
the cross-sectional study design, which prevents us from inferring causal relationships.
Generalizability of findings to parents living in other states will need to be established.
Our main finding was that healthcare providers were the only information source associated
with parents’ vaccination of their adolescent daughters. Future campaigns promoting HPV
vaccine should target healthcare providers, since results show they can be influential sources
of information for parents. An additional important public policy finding was that less than
one tenth of parents recalled vaccine information provided by their daughters’ schools,
despite a statewide requirement that schools disseminate this information. Having heard of
HPV vaccine through schools was not associated with vaccine initiation, but this may be due
to the low number of parents who had heard through schools. Policymakers in North
Carolina should explore effective ways to disseminate the required HPV information
through schools.
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Table 2
HPV vaccine initiation by source of information (n = 617)
n initiated/total Weighted % Bivariate OR (95% CI) Multivariate OR (95% CI)
Drug company ad
 No 81/217 37.7 ref. --
 Yes 115/390 28.0 0.65(0.41–1.01) --
Healthcare provider
 No 56/313 16.4 ref. ref.
 Yes 141/301 45.7 4.28(2.61–6.99)* 2.87(1.69–4.87)*
News/Internet
 No 105/303 34.4 ref. --
 Yes 87/304 27.0 0.71(0.46–1.10) --
Daughter’s school
 No 178/559 30.3 ref. --
 Yes 18/50 41.4 1.60(0.77–3.36) --
Note. HPV = human papillomavirus, OR = odds ratio, CI = confidence interval, ref. = referent group. Does not include respondents who did not
know if they had heard about HPV vaccine from this source (drug company advertisement n=10; healthcare provider n=3; news/Internet n=10; and
daughter’s school n=8). Multivariate model controlled for variables previously found to be associated with HPV vaccine initiation in this data set
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